SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNSS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/10	07 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/27	08 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/27	08 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/27	08 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/09	05 : 24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/06	05 : 53	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/03	05 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/04/28	05 : 16	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/04/28	05 : 09	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/04/01	05 : 36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/18	06 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/15	06 : 14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/01	08 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/01	08 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/01	08 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/02/14	20 : 03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/01/11	07 : 22	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07 : 18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/11	06 : 38	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/11	06 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/09/20	08 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc